Rhabdomyosarcoma and Weakness
Summary:
Weakness is found among people with Rhabdomyosarcoma, especially for people who are female, 60+ old.
The study analyzes which people have Weakness with Rhabdomyosarcoma. It is created by eHealthMe based on reports of 149 people who have Rhabdomyosarcoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Rhabdomyosarcoma?
Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)) is found to be associated with 66 drugs and 310 conditions by eHealthMe. Check the latest studies of Rhabdomyosarcoma.
What is Weakness?
Weakness is found to be associated with 3,640 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.
149 people who have Rhabdomyosarcoma and Weakness are studied.
Gender of people who have Rhabdomyosarcoma and experienced Weakness *:
Age of people who have Rhabdomyosarcoma and experienced Weakness *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Weakness?
- Check whether Weakness is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Rhabdomyosarcoma (6,271 reports)
- Weakness (586,876 reports)
All the drugs that are associated with Weakness:
- Weakness (3,640 drugs)
All the conditions that are associated with Weakness:
- Weakness (6,612 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Weakness and Rhabdomyosarcoma, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Skyla cause Hair Loss? - 3 seconds ago
- Insomnia and Confusion - 9 seconds ago
- Could Emend cause Blood Phosphorus Decreased? - 26 seconds ago
- Could Skyclarys cause Fatigue? - 31 seconds ago
- Could Nitro-Bid cause Headache? - 51 seconds ago
- Could Adrenalin cause Weakness? - 58 seconds ago
- Osteopenia and Fistula Discharge - a minute ago
- Could Quillichew Er cause Headache? - a minute ago
- Drug interactions of Azilect and Zolpidem - a minute ago
- Could Cyclosporine cause Hyperkalemia? - a minute ago